Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, GRB-504, Boston, Massachusetts 02114, USA.
Gastroenterology. 2011 Feb;140(2):686-696.e1. doi: 10.1053/j.gastro.2010.09.042. Epub 2010 Sep 24.
BACKGROUND & AIMS: HLA class I alleles are linked to spontaneous control of hepatitis C virus (HCV) and human immunodeficiency virus-1, but for HCV the roles of particular alleles and corresponding CD8(+) T-cell responses remain incompletely defined. We aimed to determine the correlations between these alleles and natural outcomes of HCV and determine associated key T-cell responses.
In a cohort of HCV individuals, we determined HLA class I alleles, HCV outcomes, T-cell responses, and examined sequence data for mutational changes within key epitopes.
Carriage of HLA-B 57 was associated with a higher rate of viral clearance (risk ratio = 2.0; 95% confidence interval: 1.2-3.4), while HLA-B 08 was associated with a lower rate (risk ratio = 0.34; 95% confidence interval: 0.1-0.9]. Two HLA-B 57-restricted T-cell epitopes were targeted in spontaneous clearance; subjects with chronic viremia expressing HLA-B 57 harbored HCV strains with a high frequency of mutations in key residues. HLA-B 57-mediated escape was supported by diminished immune recognition of these variants and acute HCV infection revealing viral evolution toward less recognized variants. Analysis of a genotype 1b strain from a single-source HCV outbreak in which HLA-B 57 was not protective revealed sequence variations that interfere with immunogenicity, thereby preventing HLA-B 57-mediated immune pressure.
Our data indicate a role of HLA-B 57-restricted CD8(+) T-cell responses in mediating spontaneous clearance and evolution in HCV infection, and viral strains containing epitope variants that are less recognized abrogate the protective effects of HLA-B 57. The finding that HLA-B 57-mediated antiviral immunity is associated with control of both human immunodeficiency virus-1 and HCV suggests a common shared mechanism of a successful immune response against persistent viruses.
HLA Ⅰ类等位基因与丙型肝炎病毒(HCV)和人类免疫缺陷病毒-1 的自发控制有关,但对于 HCV,特定等位基因和相应的 CD8+T 细胞反应的作用仍不完全明确。我们旨在确定这些等位基因与 HCV 的自然结局之间的相关性,并确定相关的关键 T 细胞反应。
在 HCV 个体的队列中,我们确定了 HLA Ⅰ类等位基因、HCV 结局、T 细胞反应,并检查了关键表位内突变变化的序列数据。
携带 HLA-B57 与更高的病毒清除率相关(风险比=2.0;95%置信区间:1.2-3.4),而 HLA-B08 与更低的清除率相关(风险比=0.34;95%置信区间:0.1-0.9]。两个 HLA-B57 限制性 T 细胞表位在自发性清除中被靶向;表达 HLA-B57 的慢性病毒血症患者的 HCV 株在关键残基中具有高频突变。HLA-B57 介导的逃逸得到了这些变体免疫识别减弱的支持,以及急性 HCV 感染揭示了病毒向较少识别的变体进化。对来自 HCV 单一来源暴发的 1 型 b 株的分析表明,存在干扰免疫原性的序列变异,从而防止 HLA-B57 介导的免疫压力。
我们的数据表明,HLA-B57 限制性 CD8+T 细胞反应在介导 HCV 感染中的自发性清除和进化中起作用,并且包含较少被识别的表位变体的病毒株消除了 HLA-B57 的保护作用。HLA-B57 介导的抗病毒免疫与人类免疫缺陷病毒-1 和 HCV 的控制有关,这表明针对持续性病毒的成功免疫反应具有共同的机制。